Search

Your search keyword '"Lega, Jean‐Christophe"' showing total 470 results

Search Constraints

Start Over You searched for: Author "Lega, Jean‐Christophe" Remove constraint Author: "Lega, Jean‐Christophe"
470 results on '"Lega, Jean‐Christophe"'

Search Results

1. French protocol for the diagnosis and management of giant cell arteritis

2. Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

3. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

4. Management and Outcome of COVID-19 Positive and Negative Patients in French Emergency Departments During the First COVID-19 Outbreak: A Prospective Controlled Cohort Study

8. Early-onset autoimmunity associated with SOCS1 haploinsufficiency.

9. Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis

10. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

12. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

13. Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)

17. Heart and systemic sclerosis—findings from a national cohort study.

18. Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders

22. Long-term follow-up of the STOPAGO study

24. Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract

25. Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis.

26. ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance

28. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts

29. Sécurité des agents biologiques dans les maladies rhumatismales pédiatriques : étude rétrospective multicentrique en situation réelle dans la base de données JIRcohorte

31. Monogenic lupus: Dissecting heterogeneity

33. Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database

38. Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry

42. Heart and systemic sclerosis—findings from a national cohort study

43. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

44. Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies

46. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry.

47. Association between immune‐related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis.

Catalog

Books, media, physical & digital resources